Medigene AG
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Medigene AG
Sep 24, 2024, 15:01 |
Blog
Medigene to Host Virtual R&D Event on their Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
Medigene AG, an oncology platform company focused on the research and development of T cell…
Sep 7, 2024, 14:50 |
Blog
Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications
Medigene AG, an oncology platform company focused on the research and development of T cell…
Aug 23, 2024, 16:10 |
Blog
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
Medigene AG, an oncology platform company focused on the research and development of T cell…
Aug 13, 2024, 07:26 |
Blog
Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T-Cell Engagers
Medigene AG and WuXi Biologics enter into a three-year, multi-target strategic partnership to design and co-research…
Jul 7, 2024, 07:08 |
Insight
Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jul 1, 2024, 09:17 |
Blog
Medigene Reports Results of Annual General Meeting
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jun 2, 2024, 22:26 |
Blog
Medigene AG Expands its End-to-End Platform by Submitting Three Patents to the European Patent Office
Medigene AG an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies…
May 23, 2024, 07:44 |
Blog
Medigene's Global Research and Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
Medigene AG an immuno-oncology platform company focusing on the discovery and development of differentiated T cell…
May 16, 2024, 08:20 |
Blog
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise Cash runway…
Apr 20, 2024, 08:16 |
Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
All:
10
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube